EVOlve your news

All the news related to the Evobiotech world: a world made of discoveries, research and funding

News

PUBLICATION

17th March 2023

Turin

EVOBIOTECH PUBLISHED ITS LATEST WORK ON THE USE OF ITS TECHNOLOGY AS A DELIVERY SYSTEM FOR SARS-COV-2 MRNA VACCINES

EvoBiotech is proud to announce its latest publication on the use of extracellular vesicles derived from plants as a drug delivery system in the special issue “Advances of Membrane Vesicles in Drug Delivery Systems” of Pharmaceutics Journal. This work demonstrates the use of edible plant-derived extracellular vesicles to vehicle mRNA-based vaccines for SARS-CoV-2 using intramuscular, […]

PUBLICATION

27th January 2023

Turin

EVOBIOTECH’S TECHNOLOGY FOR DRUG DELIVERY IN A NEW PUBLICATION

An Opinion paper entitled “Plant-Derived Extracellular Vesicles as a Platform for Drug Delivery” was just published in Innovations in Tissue Engineering & Regenerative Medicine. The publication describes the advantages of plant-derived extracellular vesicles as carriers and their relevance for the future of drug delivery. The complete article at the link: https://crimsonpublishers.com/iterm/pdf/ITERM.000523.pdf

GOALS

24th January 2023

Turin

EVOBIOTECH SUCCESSFULLY COMPLETED THE INCUBATION PROGRAM

Evobiotech received the recognition for the successful completion of the incubation program 2019-2022 of Incubatore d’Imprese 2i3T. Three years of growth and activities that brought the company to develop multiple therapeutic platforms using plant-derived extracellular vesicles.

BOARD AND TEAM

14th November 2022

Turin

EVOBIOTECH APPOINTS MARCO DIECI AS BOARD MEMBER AND COO

Turin, November 14th 2022 EvoBiotech S.r.l. announces the appointment of Mr. Marco Dieci as member of the Board and Chief Operating Officer. EvoBiotech is a Biotech company developing a novel technology platform using plant-derived Extracellular Vesicles (EV) aimed at improving the healing efficacy of advanced dressings and medications used in wound care treatments and at […]

INVESTMENTS AND FUNDRAISING

6th August 2021

Turin

EVOBIOTECH GETS A “SEED” FUNDING OF € 1 MILLION for the development of new vaccines and therapies based on extracellular vesicles of plant origin

EvoBiotech, an innovative start-up operating in the biotechnology sector, announces the entry into the share capital of Nocturnal Labs SpA, an Operational Holding Company with a strong innovative vision, and of LuMar. The “seed” investment for a total of € 1 million to EvoBiotech is intended for the development of a project on extracellular vesicles […]

FAIRS AND SYMPOSIUMS

10-11th December 2019

Marseille

Biofit 9th Edition

EvoBiotech has been selected to pitch at the Start-up Slams competition, during Biofit 9th Edition. Start-up Slams is an important international pitching session for young start-ups working in Life Sciences field. The event was organized during the Biofit, the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, […]

FAIRS AND SYMPOSIUMS

5th-6th June 2019

Rimini

59 SIMPOSIO AFI

EvoBiotech has been selected to pitch at the start-up event (la piazza delle start-up) of the 59th symposium organized by the Italian association of pharmaceutical industries (Associazione Farmaceutici Industria – AFI).

PITCHING MATCHES

29th October 2019

Alessandria

Start CUP Piemonte Valle d’Aosta 2019

EvoBiotech has been selected as one of the 10 finalist projects at the StartCUP Piemonte Valle d’Aosta XV Edition 2019 and has won the Special Mention ‘Pari Opportunità’. The event was organized within the “National Award for Innovation”, promoted by PNI Cube (the Italian University Incubators Association).

PITCHING MATCHES

27th June 2019

Turin

EUROPEAN STARTUP FESTIVAL

EvoBiotech has been selected to the Turin pitching match organized by European Start-up Festival and hosted by I3P, the incubator of the Politecnico di Torino.